An experimental COVID-19 treatment pill, called molnupiravir is being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.
The Africa Centres for Disease Control and Prevention had announced last week it was negotiating for supplies of Paxlovid, joining a global race for a drug seen as a potential game changer in fighting the virus. “The Pfizer arrangement is far advanced … In time, if we narrow this down and finalise … with Pfizer, I’m sure we’ll engage with Merck as well,” he said at a news briefing.
Merck has said it expects molnupiravir to be effective against the highly contagious Omicron, which has driven a surge in cases across the world.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BusinessTechSA - 🏆 24. / 61 Read more »
Source: BusinessTechSA - 🏆 24. / 61 Read more »
PODCAST: Vodacom CEO Shameel Joosub on mobile money in AfricaShameel Joosub spoke to FM columnist Toby Shapshak about the future of fintech in Africa
Source: FinancialMail - 🏆 20. / 63 Read more »
Source: eNCA - 🏆 49. / 51 Read more »
Source: BusinessTechSA - 🏆 24. / 61 Read more »
Twelve bouts to feature on ESPN Africa next weekESPN Africa will begin its quest to showcase the continent’s boxing talent to international audiences from next week.
Source: SowetanLIVE - 🏆 13. / 63 Read more »